[ Price : $8.95]
FDA approves an expanded use for Eisai Inc.s Aricept treating severe dementia in patients with Alzheimer's disease.[ Price : $8.95]
A new study finds little benefit for Alzheimers patients in commonly used off-label atypical antipsychotic drugs.[ Price : $8.95]
Consulting editor John Scharmann asks whether FDA enforcement of GMPs should give way to a new and more measurable quality complia...[ Price : $8.95]
FDA tentatively approves a Teva Pharmaceutical Industries ANDA for a generic version of Janssen's Risperdal.[ Price : $8.95]
FDA approves Genentechs cancer drug Avastin for combination use with carboplatin and paclitaxel in non-small cell lung cancer pati...[ Price : $8.95]
Four-fifths of doctors surveyed by MedPanel say they favor an enforced moratorium on DTC ads for newly-approved drugs.[ Price : $8.95]
A DDMAC Warning Letter says a BioMarin Web site for Orapred minimizes risk, broadens the indication, and makes unsubstantiated com...[ Price : $8.95]
Solvay Pharmaceuticals and Wyeth Pharmaceuticals submit an NDA for bifeprunox, an atypical antipsychotic indicated for treating sc...